The French Observatory of Drugs and Drug Addiction (OFDT) and Public Health France publish the results of the level of use of illicit drugs in France from 1992 to 2017
This survey interviewed more than 20 000 seniors from 18 to 64 years on the uses of these substances.
The points to remember for cannabis:
1.Consumption of cannabis more and more frequent beyond 25 years
In 2017, cannabis remains the first illicit substance disseminated in the population: 44,8% of adults have already tested at least once, with a prevalence higher in men. Since 1992, the spread of cannabis has continued to grow: its experimentation rate is passed from 12,7% 1992 alone à 44.8% in 2017.
L'augmentation levels of use in the year touches all generations but is particularly sensitive among adults from 35 to 44 years
Usage in the year or Regular Use has undergone an increase of 6% in 30 years he goes from 4,4% à 11,0% and between 1992 2017.
Concerning more specifically the latest developments (period 2014-2017), theuse in the year stays at a level of 11,0% from 18 64-years. This use gradually decreases with age, passing 26,9% for 18 25-years à 17,7% for 26 - 34 years, 9,4% in those aged 35 44 years to et 1,6% among the oldest 55 64-years.
2. More cannabis users among active, employed or unemployed people.
In 2017, the unemployed present levels of current use of cannabis almost twice as high that busy assets. These levels ofuse in the year tripled between 1992 and 2017, both among the employed (from 3,5% to 9,6%) and the unemployed (from 5,0% to 15,8%). Between 2014 and 2017, it seems that the difference has slightly decreasedbecause of a rise in consumption among the employed and a stabilization of that of the unemployed.
3.Autoculture of cannabis, a practice more and more widespread.
The black market is the most frequent mode of supply: almost two-thirds of users say they have used it, while 7% mention practicing home growing.
Similar to what is observed for cannabis, the levels of experimentation of the other drugs differ considerably according to the sex and the age of the individuals. For all products, men are more often experimentalists than women.
The results of the seventh exercise of the Public Health France Health Barometer mainly concern younger generations and men. Several levels of use in 2017 are generally stable compared to those of 2014. In 2017, the share of cannabis experimenters has continued to increase and now affects almost half of adults. The use of cocaine and MDMA / ecstasy is increasing more frequently than before beyond the key age group 18-25 years, reflecting the increased accessibility and availability of these products.